The US Food and Drug Administration (FDA) has approved Allergan’s drug-releasing implant, Durysta, for administration within the cavities of the eye to reduce intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
YOUR SOURCE FOR THE BEST ASSISTIVE TECH NEWS, REVIEWS AND INTERVIEWS FROM TOP BLIND AND LOW VISION EXPERTS. AN ENTERTAINING AND TRUSTWORTHY DISCUSSION ON EMERGING TECHNOLOGIES
You must be logged in to post a comment.